I would think "sit back and enjoy the ride"!
So long as EMV continues to be the/a leader in this disruptive tech.
It is clear that the tech is desperately needed (we know that from ASA work and Ron's reports from biomedical conferences in the USA).
The task for Emvision is to tweak the algos and then house the tech in user-friendly devices with the right sized and shaped footprints (for hassle-free accommodation in ambulances, aircraft, ships, smaller clinics etc.) and at affordable, attractive price points.
If they can achieve all that - and they have the team to give it a red-hot go - the sky will be the limit.
They can then perhaps leverage that success quite quickly into the torso scanner (for fatty liver disease and perhaps others).
Only if the above falls apart will I be considering anything other than 'sit back and enjoy the ride?'
I would think "sit back and enjoy the ride"! So long as EMV...
-
- There are more pages in this discussion • 33 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add EMV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.96 |
Change
-0.005(0.25%) |
Mkt cap ! $167.4M | |||
| Open | High | Low | Value | Volume |
| $1.94 | $1.96 | $1.94 | $13.90K | 7.144K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 233 | $1.97 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.98 | 1045 | 1 |
View Market Depth
| Last trade - 11.09am 19/07/2024 (20 minute delay) ? |
| EMV (ASX) Chart |